hydration benefits glp-1 receptor agonist therapy and Low Blood Pressure: Symptoms, Risks, and Management IUPHAR review – Glucagon-like peptide-1

I am scared about the pancreatic insufficiency

It is a growth hormone-releasing peptide and ghrelin mimetic

6 Challenges for clinical use of IGF-1R-silencing agents 6.1 Toxicity of IGF-1R antagonists Clinical trials of a large number IGF-1/2, IGF-1R, IRS-1, PI3K and mTOR antagonists have been abandoned due to limited anti-cancer activity, or to the toxicity of these agents (41, 53), further supporting the need to continue studies on LL6 and other molecules that are well tolerated in mice and effective at doses that are not toxic to normal cells (54)

So I'm super, super stoked, you know

CJC 1295 and Ipamorelin should be used under medical supervision and administered via subcutaneous injection

10.1176/ajp.2006.163.11.1905 75